Complementary and Alternative Care in Multiple Sclerosis

Complementary and Alternative Medicine (CAM) in Multiple Sclerosis. A Prospective Observational Study of a CAM-using Cohort

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01703429

Acronym

CAM Care in MS

Enrollment

1000

Registered

2012-10-10

Start date

2012-06-30

Completion date

2030-06-30

Last updated

2020-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Multiple Sclerosis, MS, Complementary and Alternative, CAM

Brief summary

This is a prospective, observational study designed to describe disease progression, symptom change, quality of life, diet and lifestyle habits, and frequency of adverse events among patients with multiple sclerosis (MS) who use complementary and alternative medicine (CAM). In addition to describing the patterns of CAM use, this study will also identify and describe the positive deviants, those individuals with the highest quality of life and least amount of disease activity. Positive deviants will be compared to controls in order to describe medication, diet, and lifestyle patterns associated with a lack of MS disease progression and high quality of life.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Diagnosis of multiple sclerosis (including relapsing remitting MS, secondary progressive MS, primary progressive MS, clinically isolated syndromes (CIS), radiologically-isolated syndromes (RIS), possible MS, or probable MS. * Age 18-100

Exclusion criteria

* Inability to read/write in English * Inability or unwillingness to complete surveys every six (6) months. (\ 90 min)

Design outcomes

Primary

Measure	Time frame	Description
CAM Therapies survey	5 years	This survey has been developed to identify the complementary and alternative therapies most commonly used by individuals with MS. Results will be reported with descriptive statistics.

Secondary

Measure	Time frame	Description
Modified Expanded Disability Severity Score (EDSS)	5 years	The EDSS will be used to capture disease severity and rates of progression in this cohort.

Other

Measure	Time frame	Description
PROMIS: Global Health	5 years	This outcome measure will be used to assess general health and well-being in this CAM using cohort.

Countries

United States

Contacts

Primary ContactResearch Assistant

neuroresearch@bastyr.edu

Outcome results